In a 36-year-old woman taking medroxyprogesterone acetate (Provera) 5–10 mg daily for 10–14 days each month to regulate menstrual cycles, does the medication cause weight gain?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 4, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Does Provera Cause Weight Gain?

Yes, medroxyprogesterone acetate (Provera) can cause weight gain, but the evidence shows this effect is primarily associated with the high-dose injectable formulation (DMPA/Depo-Provera) rather than the low-dose oral formulation used for menstrual regulation.

Key Distinction: Formulation Matters

The critical factor is which formulation of medroxyprogesterone acetate is being used:

Injectable DMPA (Depo-Provera): Clear Weight Gain Risk

Evidence of weight gain with injectable DMPA is well-established 1. A Cochrane review specifically demonstrated evidence of weight gain associated with medroxyprogesterone acetate in progestin-only contraceptives 1. Studies show:

  • DMPA users gained significantly more weight and body fat compared to non-hormonal contraceptive users 2
  • Mean weight increased from 69.4 kg at baseline to 75.5 kg at 30 months (6.1 kg gain, 8.8% increase) 2
  • Fat mass increased by 6.1 kg (23.6%) over the same period 2
  • The mechanism appears to be fat deposition rather than fluid retention 3
  • Weight gain is associated with increased central fat distribution 2

Oral Provera (5-10 mg for 10-14 days/month): Minimal Evidence

For the oral formulation used cyclically for menstrual regulation (your patient's scenario), the evidence for clinically significant weight gain is much weaker. The FDA label lists "increase in weight" as a possible side effect 4, but this is based on spontaneous reporting rather than controlled trials showing substantial weight changes.

Clinical Context for Your Patient

For a 36-year-old woman taking oral Provera 5-10 mg daily for 10-14 days per month:

The risk of significant weight gain is low. This cyclic, low-dose oral regimen differs substantially from the high-dose injectable formulation where weight gain is well-documented. The guideline evidence discussing progestogen use for endometrial protection in this dosing pattern does not highlight weight gain as a major concern 5.

What to Monitor

  • Baseline weight documentation is reasonable for future comparison
  • If weight gain occurs, consider confounding factors: life circumstances, stress, dietary changes, reduced physical activity 6
  • The FDA label notes other common side effects that may be more relevant: bloating, fluid retention, breast tenderness 4

Important Caveats

  • Individual variation exists: Some women may experience weight changes even with oral formulations
  • Fluid retention (from progestogenic effects) may cause temporary weight fluctuations or bloating, which differs from true fat mass gain 4
  • Perception vs. reality: Studies show that perceived weight gain often reflects lifestyle factors rather than direct hormonal effects 6

Bottom Line

Counsel your patient that oral Provera at this dose and schedule has minimal evidence for causing significant weight gain. If she experiences weight changes, evaluate other contributing factors first. The strong weight gain signal is specific to injectable DMPA, not the oral cyclic regimen used for menstrual regulation.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.